Hudson Bay Capital Management’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $34.8M | Buy |
66,358
+45,771
| +222% | +$24M | 0.12% | 87 |
|
|
2025
Q1 | $13.1M | Buy |
20,587
+5,581
| +37% | +$3.54M | 0.04% | 200 |
|
|
2024
Q4 | $10.7M | Sell |
15,006
-14,346
| -49% | -$10.2M | 0.04% | 239 |
|
|
2024
Q3 | $30.9M | Buy |
29,352
+13,294
| +83% | +$14M | 0.12% | 74 |
|
|
2024
Q2 | $16.9M | Buy |
+16,058
| New | +$16.9M | 0.08% | 102 |
|
|
2024
Q1 | – | Sell |
-41,500
| Closed | -$36.4M | – | 753 |
|
|
2023
Q4 | $36.4M | Buy |
+41,500
| New | +$36.4M | 0.23% | 51 |
|
|
2023
Q3 | – | Sell |
-600
| Closed | -$431K | – | 832 |
|
|
2023
Q2 | $431K | Buy |
+600
| New | +$431K | ﹤0.01% | 561 |
|
|
2023
Q1 | – | Sell |
-13,400
| Closed | -$9.67M | – | 912 |
|
|
2022
Q4 | $9.67M | Buy |
+13,400
| New | +$9.67M | 0.1% | 159 |
|
|
2021
Q2 | – | Sell |
-38,000
| Closed | -$18M | – | 992 |
|
|
2021
Q1 | $18M | Sell |
38,000
-500
| -1% | -$237K | 0.22% | 58 |
|
|
2020
Q4 | $18.6M | Buy |
+38,500
| New | +$18.6M | 0.2% | 62 |
|
|
2020
Q1 | – | Sell |
-30,000
| Closed | -$11.3M | – | 555 |
|
|
2019
Q4 | $11.3M | Sell |
30,000
-17,500
| -37% | -$6.57M | 0.25% | 67 |
|
|
2019
Q3 | $13.2M | Buy |
47,500
+25,000
| +111% | +$6.94M | 0.36% | 49 |
|
|
2019
Q2 | $7.04M | Buy |
+22,500
| New | +$7.04M | 0.16% | 116 |
|
|
2018
Q4 | – | Sell |
-15,000
| Closed | -$6.06M | – | 567 |
|
|
2018
Q3 | $6.06M | Sell |
15,000
-10,000
| -40% | -$4.04M | 0.07% | 129 |
|
|
2018
Q2 | $8.63M | Buy |
25,000
+15,000
| +150% | +$5.18M | 0.12% | 77 |
|
|
2018
Q1 | $3.44M | Buy |
+10,000
| New | +$3.44M | 0.07% | 177 |
|